Your browser doesn't support javascript.
loading
JAK-STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States.
Stevens, Laura E; Peluffo, Guillermo; Qiu, Xintao; Temko, Daniel; Fassl, Anne; Li, Zheqi; Trinh, Anne; Seehawer, Marco; Jovanovic, Bojana; Aleckovic, Masa; Wilde, Callahan M; Geck, Renee C; Shu, Shaokun; Kingston, Natalie L; Harper, Nicholas W; Almendro, Vanessa; Pyke, Alanna L; Egri, Shawn B; Papanastasiou, Malvina; Clement, Kendell; Zhou, Ningxuan; Walker, Sarah; Salas, Jacqueline; Park, So Yeon; Frank, David A; Meissner, Alexander; Jaffe, Jacob D; Sicinski, Piotr; Toker, Alex; Michor, Franziska; Long, Henry W; Overmoyer, Beth A; Polyak, Kornelia.
Affiliation
  • Stevens LE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Peluffo G; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
  • Qiu X; Department of Medicine, Harvard Medical School, Boston, Massachusetts.
  • Temko D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Fassl A; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
  • Li Z; Department of Medicine, Harvard Medical School, Boston, Massachusetts.
  • Trinh A; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Seehawer M; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Jovanovic B; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Aleckovic M; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, Massachusetts.
  • Wilde CM; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Geck RC; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, Massachusetts.
  • Shu S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Kingston NL; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
  • Harper NW; Department of Medicine, Harvard Medical School, Boston, Massachusetts.
  • Almendro V; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Pyke AL; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
  • Egri SB; Department of Medicine, Harvard Medical School, Boston, Massachusetts.
  • Papanastasiou M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Clement K; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
  • Zhou N; Department of Medicine, Harvard Medical School, Boston, Massachusetts.
  • Walker S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Salas J; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
  • Park SY; Department of Medicine, Harvard Medical School, Boston, Massachusetts.
  • Frank DA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Meissner A; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
  • Jaffe JD; Department of Medicine, Harvard Medical School, Boston, Massachusetts.
  • Sicinski P; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Toker A; Department of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Michor F; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Long HW; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
  • Overmoyer BA; Department of Medicine, Harvard Medical School, Boston, Massachusetts.
  • Polyak K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Cancer Res ; 83(2): 264-284, 2023 01 18.
Article in En | MEDLINE | ID: mdl-36409824
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Inflammatory Breast Neoplasms Limits: Female / Humans Language: En Journal: Cancer Res Year: 2023 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Inflammatory Breast Neoplasms Limits: Female / Humans Language: En Journal: Cancer Res Year: 2023 Document type: Article Country of publication: United States